M2D2 Impact is a 12-week accelerator program that aims to advance early-stage companies looking to reshape the future of healthcare.
THE IMPACT PROGRAM IS CURRENTLY ACCEPTING APPLICATIONS FOR CYCLE 6
What is IMPACT?
IMPACT is a 12-week accelerator program that uses a unique 1:1 approach and is created to connect startups with resources needed for commercialization. RQMIS is one of UMass Lowell's M2D2 corporate partners. Companies selected will have the opportunity to engage with RQMIS and gain key development advice and guidance.
For Cycle 6, the IMPACT program is seeking startups developing solutions in these areas of interest:
Digital Health: Physician or patient products targeting chronic conditions to reduce hospital admission and/or re-admissions
Diagnostic Tools Collecting Patient Data: Physician or patient products targeting chronic conditions to reduce hospital admission and/or re-admissions
How past IMPACT members feel about the program.
"The content of the live events was excellent, and the support and encouragement offered by M2D2’s leadership team was exceptional."
Laura Owen, CEO & Founder of HealthyID
"The IMPACT team assisted with key introductions to investors and strategic partners."
Gitte Pederson, CEO & Co-founder of Genomic Expression
"We were thrilled to be accepted into the program, and our expectations were only exceeded."
Ben Merewitz, CEO & Co-founder of Agile Devices
"The accelerator had a positive impact on Avisi and we highly recommend it to other startups like us.”
Rui Jing Jiang, CEO & Co-founder of Avisi
"We would recommend the IMPACT program to any startup willing to learn and advance their company to the next level.”
Bryan Nolan, CEO & Founder of myBiometry
"I cannot recommend M2D2 IMPACT enough.”
Casey Grage, CEO & Founder of Hubly Surgical